According to Pieris Pharmaceuticals's latest financial reports the company's current revenue (TTM) is โน3.32 B. In 2022 the company made a revenue of โน2.14 B a decrease over the revenue in the year 2021 that were of โน2.34 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.